Aziende Chimiche Riunite Angelini Francesco ACRAFSpA v. Aurobindo Pharma USA Inc.
Plaintiff: Aziende Chimiche Riunite Angelini Francesco ACRAFSpA
Defendant: Aurobindo Pharma USA Inc.
Case Number: 1:2019cv02197
Filed: November 25, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on January 10, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
January 10, 2020 Filing 6 WAIVER OF SERVICE returned executed by Aziende Chimiche Riunite Angelini Francesco ACRAFSpA: For Aurobindo Pharma USA Inc. waiver sent on 12/3/2019, answer due 2/3/2020. (Pascale, Karen)
November 27, 2019 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
November 26, 2019 Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA Inc. on 11/26/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam)
November 25, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Angelini Holding S.p.A. (formerly known as Finaf S.p.A.) for Aziende Chimiche Riunite Angelini Francesco ACRAFSpA filed by Aziende Chimiche Riunite Angelini Francesco ACRAFSpA. (sam)
November 25, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number 8,133,893 (sam)
November 25, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 15, 2019. Date of Expiration of Patent: May 12, 2030.Thirty Month Stay Deadline: 04/15/2022. (sam)
November 25, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
November 25, 2019 Filing 1 COMPLAINT filed against Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2787789.) - filed by Aziende Chimiche Riunite Angelini Francesco ACRAFSpA. (Attachments: #1 Certificate of Compliance A, #2 Civil Cover Sheet)(sam)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Aziende Chimiche Riunite Angelini Francesco ACRAFSpA v. Aurobindo Pharma USA Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma USA Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Aziende Chimiche Riunite Angelini Francesco ACRAFSpA
Represented By: Robert M. Vrana
Represented By: Karen L. Pascale
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?